Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean W Felsher

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2023
MYC-driven synthesis of Siglec ligands is a glycoimmune checkpointBenjamin A H Smith, Anja Deutzmann, Kristina M Correa, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 2015
MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolismEmelyn H Shroff, Livia S Eberlin, Vanessa M Dang, et al.
Cell Metabolism|August 27, 2019
The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic GrowthArvin M Gouw, Katherine Margulis, Natalie S Liu, et al.
Elife|January 15, 2020
<i>MYC</i> and <i>Twist1</i> cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunityRenumathy Dhanasekaran, Virginie Baylot, Minsoon Kim, et al.
Plos One|September 26, 2009
Cell cycle re-entry and mitochondrial defects in myc-mediated hypertrophic cardiomyopathy and heart failureHyoung-gon Lee, Qun Chen, Julie A Wolfram, et al.
Nature Communications|April 8, 2025
Lactobacillus acidophilus potentiates oncolytic virotherapy through modulating gut microbiota homeostasis in hepatocellular carcinomaJiayu Zhang, Jinneng Yang, Jinyan Luo, et al.
Cancer Research|March 8, 2013
Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancerWan-chi Lin, Nirakar Rajbhandari, Chengbao Liu, et al.
Nature|March 3, 2016
NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesisChi Ma, Aparna H Kesarwala, Tobias Eggert, et al.
Leukemia Research|October 14, 2016
KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 studyRonan T Swords, Peter L Greenberg, Andrew H Wei, et al.
Plos Genetics|June 2, 2012
Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesisPhuoc T Tran, Emelyn H Shroff, Timothy F Burns, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2023
MYC-driven synthesis of Siglec ligands is a glycoimmune checkpointBenjamin A H Smith, Anja Deutzmann, Kristina M Correa, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 2015
MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolismEmelyn H Shroff, Livia S Eberlin, Vanessa M Dang, et al.
Cell Metabolism|August 27, 2019
The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic GrowthArvin M Gouw, Katherine Margulis, Natalie S Liu, et al.
Elife|January 15, 2020
<i>MYC</i> and <i>Twist1</i> cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunityRenumathy Dhanasekaran, Virginie Baylot, Minsoon Kim, et al.
Plos One|September 26, 2009
Cell cycle re-entry and mitochondrial defects in myc-mediated hypertrophic cardiomyopathy and heart failureHyoung-gon Lee, Qun Chen, Julie A Wolfram, et al.
Nature Communications|April 8, 2025
Lactobacillus acidophilus potentiates oncolytic virotherapy through modulating gut microbiota homeostasis in hepatocellular carcinomaJiayu Zhang, Jinneng Yang, Jinyan Luo, et al.
Cancer Research|March 8, 2013
Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancerWan-chi Lin, Nirakar Rajbhandari, Chengbao Liu, et al.
Nature|March 3, 2016
NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesisChi Ma, Aparna H Kesarwala, Tobias Eggert, et al.
Leukemia Research|October 14, 2016
KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 studyRonan T Swords, Peter L Greenberg, Andrew H Wei, et al.
Plos Genetics|June 2, 2012
Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesisPhuoc T Tran, Emelyn H Shroff, Timothy F Burns, et al.
Pageof 15